Cost Offset With Quadruple Therapy for Heart Failure

JAMA Cardiology · Published 2026-06-10 · DOI 10.1001/jamacardio.2026.1552

Free full text

Authors (8)

Mohammad Keykhaei, Sina Rashedi, Stephen J. Greene, Clyde Yancy, Boback Ziaeian, Alexander T. Sandhu, Michelle Kittleson, Gregg C. Fonarow

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Keykhaei, M., Rashedi, S., Greene, S., et al. (2026). Cost Offset With Quadruple Therapy for Heart Failure. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2026.1552

Related articles

• Projected US Cardiovascular Disease Burden From Heat Exposure for Future Greenhouse Gas Scenarios · JAMA Cardiology · 2026 · Same journal
• Warming Planet, Aging Population, and Cardiovascular Crisis · JAMA Cardiology · 2026 · Same journal
• Exercise Testing and the Evolving Management of Asymptomatic Severe Aortic Stenosis · JAMA Cardiology · 2026 · Same journal
• Unanswered Questions in Aldosteronism and Cardiovascular Risk · JAMA Cardiology · 2026 · Same journal
• Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages · JAMA Cardiology · 2026 · Same journal
• Notes From the Far End of the Stethoscope · JAMA Cardiology · 2026 · Same journal
• AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia · JAMA Cardiology · 2026 · Same journal
• Unanswered Questions in Aldosteronism and Cardiovascular Risk—Reply · JAMA Cardiology · 2026 · Same journal
• Abnormal Echocardiogram in the Setting of Malignancy · JAMA Cardiology · 2026 · Same journal
• Precardioversion Heart Rhythm Monitoring Using Smartphone Photoplethysmography · JAMA Cardiology · 2026 · Same journal